Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000286384 refers to a novel, uncharacterized non-coding RNA transcript located antisense to the Contactin-associated protein-like 5 (CNTNAP5) gene on the human genome. Antisense non-coding RNAs can regulate the expression of their sense gene partners through diverse mechanisms, including transcriptional interference, RNA masking, double-stranded RNA-dependent silencing, and chromatin modification[2][4]. There is no published evidence for protein-coding potential, therapeutic relevance, or specific biological function of this transcript in humans.\n\nKey context and rationale:\n- This entry appears to be a genome annotation artifact or a reference to a transcriptomic finding from large-scale sequencing, not a defined molecular target.\n- Antisense RNAs broadly modulate gene regulation and may influence the stability, splicing, or chromatin architecture of their partner genes, but individual transcripts like ENSG00000286384 are rarely therapeutically targeted and typically lack detailed characterization[2][4].\n- CNTNAP5, the sense gene, encodes a neuronal cell adhesion protein and has been studied in neurodevelopmental contexts, but "novel transcript, antisense to CNTNAP5" does not refer to a protein or functional RNA with established clinical implications.\n- Searches return no evidence this transcript is used as a target for drugs, diagnostics, or therapeutics.\n\nSummary:\nENSG00000286384 is not an established molecular target. It represents an uncharacterized antisense RNA with no current evidence for protein-coding potential, disease association, or pharmacological relevance. The provided name, description, and function are correct for transcriptomic annotation, but not for target discovery or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CNTNAP5 (ENSG00000286384).